Bio

Stephen is a Managing Director of PharmaVentures. He joined PharmaVentures in 2012, after a long career in Healthcare Investment Banking. At PharmaVentures, Stephen has originated and worked on a number of strategic advisory, licensing and M&A mandates, assisting his clients find the optimal solutions to their challenges and opportunities. Prior to joining PharmaVentures, Stephen worked as an equity research analyst at Teather & Greenwood, Commerzbank and Elixir Securities covering a range of domestic and international pharmaceutical and biotechnology companies. Subsequently Stephen moved into Corporate Finance roles within Elixir Securities and Matrix Securities, where he advised a number of public and private diagnostic, therapeutics and medical technology companies on fundraising and M&A. Before embarking on a career in the City, Stephen was instrumental in establishing Evaluate Pharma as one of the pre-eminent competitive intelligence tools in the healthcare industry. He holds a PhD in Neurology from the University of Cambridge. Although he has a broad spectrum of experience across many sub-sectors of the Healthcare space, Stephen currently has a focus on Contract Research Organisations, Diagnostic, Medical Technologies and Therapeutics companies.